ANDA 62774, held by Teva Pharms. Cefadroxil/Cefadroxil Hemihydrate.
As of Nov 16, 2026, ANDA 62774 (Cefadroxil), held by Teva Pharms, was first approved by FDA on Apr 8, 1987, with 11 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Cefadroxil tablets are indicated for the treatment of patients with infection caused by susceptible strains of the designated organisms in the following diseases: Urinary tract infections caused by E. coli, P. mirabilis, and Klebsiella species. Skin and skin structure infections caused by staphylococci and/or streptococci. Pharyngitis and/or tonsillitis caused by Streptococcus pyogenes (Group A beta-hemolytic streptococci). Note: Only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. Cefadroxil is generally effective in the eradication of streptococci from the oropharynx.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 8, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| CefadroxilEQ 1GM BASE · tablet;oral | Cefadroxil/Cefadroxil Hemihydrate | Rx |
| Apr 18, 2012 | Supplement 16Labeling | Approved | |
| Jun 30, 2008 | Supplement 14Labeling | Approved | None posted |
| Aug 23, 1999 | Supplement 6Manufacturing | Approved | None posted |
| Aug 23, 1999 | Supplement 7Manufacturing | Approved | None posted |
| Aug 23, 1999 | Supplement 8Manufacturing | Approved | None posted |
| Aug 23, 1999 | Supplement 9Labeling | Approved | None posted |
| Aug 20, 1999 | Supplement 10Manufacturing | Approved | None posted |
| Dec 9, 1998 | Supplement 5Manufacturing | Approved | None posted |
| May 30, 1997 | Supplement 4Manufacturing | Approved | None posted |
| Apr 21, 1992 | Supplement 1Manufacturing | Approved | None posted |
| Apr 21, 1992 | Supplement 3Labeling | Approved | None posted |
| Apr 8, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters